Loading…
Ventricular Tachycardia Ablation in Non-ischemic Cardiomyopathy
Non-ischemic cardiomyopathies are a heterogeneous group of diseases of the myocardium that have a distinct proclivity to ventricular arrhythmias. Of these, ventricular tachycardias pose significant management challenges with the risk of sudden cardiac death and morbidity from multiple causes. Cathet...
Saved in:
Published in: | Korean circulation journal 2020, 50(3), , pp.203-219 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c421t-aa1c6f4c6ccaac8bc38de75b102ebe190da8810c20c5253be5d6c80ba437ad6b3 |
---|---|
cites | cdi_FETCH-LOGICAL-c421t-aa1c6f4c6ccaac8bc38de75b102ebe190da8810c20c5253be5d6c80ba437ad6b3 |
container_end_page | 219 |
container_issue | 3 |
container_start_page | 203 |
container_title | Korean circulation journal |
container_volume | 50 |
creator | Bhaskaran, Ashwin De Silva, Kasun Rao, Karan Campbell, Timothy Trivic, Ivana Bennett, Richard G Kizana, Eddy Kumar, Saurabh |
description | Non-ischemic cardiomyopathies are a heterogeneous group of diseases of the myocardium that have a distinct proclivity to ventricular arrhythmias. Of these, ventricular tachycardias pose significant management challenges with the risk of sudden cardiac death and morbidity from multiple causes. Catheter ablation of ventricular tachycardias is becoming an increasingly utilised intervention that has been found to have significant benefits with improving symptoms, reducing anti-arrhythmic drug burden and debilitating device therapies, thereby improving quality of life. Nonetheless, the approach to the ablation of ventricular tachycardias in non-ischemic cardiomyopathies is governed heavily by the disease process, with several distinct differences from ischemic cardiomyopathy including a preponderance to epicardial and deep intramural substrate. This contemporary review aims to present the various disease processes within non-ischemic cardiomyopathies, catheter ablation techniques which have been developed to target ventricular tachycardia and more novel adjunctive therapeutic measures. |
doi_str_mv | 10.4070/kcj.2019.0292 |
format | article |
fullrecord | <record><control><sourceid>proquest_nrf_k</sourceid><recordid>TN_cdi_nrf_kci_oai_kci_go_kr_ARTI_6878509</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2327941594</sourcerecordid><originalsourceid>FETCH-LOGICAL-c421t-aa1c6f4c6ccaac8bc38de75b102ebe190da8810c20c5253be5d6c80ba437ad6b3</originalsourceid><addsrcrecordid>eNpVkctLw0AQxhdRfB-9So56SN1Xks1FKcUXiIJUr8tksrXbJtm6SYX-925sLTqXGZjffDPDR8gZowNJM3o1x9mAU5YPKM_5DjlkmVBxEmJ3W3N6QI7adkZpKiXP98mBYEoGhB-Sm3fTdN7isgIfjQGnKwRfWoiGRQWddU1km-jZNbFtcWpqi9Go77t65RbQTVcnZG8CVWtON_mYvN3djkcP8dPL_eNo-BSj5KyLARimE4kpIgCqAoUqTZYUjHJTGJbTEpRiFDnFhCeiMEmZoqIFSJFBmRbimFyudRs_0XO02oH9yR9Oz70evo4fdaoyldA8sNdrdrEsalNi_yFUeuFtDX71M_m_09hp0PnSGZUiT5MgcLER8O5zadpO1-F9U1XQGLdsNRc8yyVLchnQeI2id23rzWS7hlHdGxSOnOneIN0bFPjzv7dt6V9HxDeVU41-</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2327941594</pqid></control><display><type>article</type><title>Ventricular Tachycardia Ablation in Non-ischemic Cardiomyopathy</title><source>Open Access: PubMed Central</source><creator>Bhaskaran, Ashwin ; De Silva, Kasun ; Rao, Karan ; Campbell, Timothy ; Trivic, Ivana ; Bennett, Richard G ; Kizana, Eddy ; Kumar, Saurabh</creator><creatorcontrib>Bhaskaran, Ashwin ; De Silva, Kasun ; Rao, Karan ; Campbell, Timothy ; Trivic, Ivana ; Bennett, Richard G ; Kizana, Eddy ; Kumar, Saurabh</creatorcontrib><description>Non-ischemic cardiomyopathies are a heterogeneous group of diseases of the myocardium that have a distinct proclivity to ventricular arrhythmias. Of these, ventricular tachycardias pose significant management challenges with the risk of sudden cardiac death and morbidity from multiple causes. Catheter ablation of ventricular tachycardias is becoming an increasingly utilised intervention that has been found to have significant benefits with improving symptoms, reducing anti-arrhythmic drug burden and debilitating device therapies, thereby improving quality of life. Nonetheless, the approach to the ablation of ventricular tachycardias in non-ischemic cardiomyopathies is governed heavily by the disease process, with several distinct differences from ischemic cardiomyopathy including a preponderance to epicardial and deep intramural substrate. This contemporary review aims to present the various disease processes within non-ischemic cardiomyopathies, catheter ablation techniques which have been developed to target ventricular tachycardia and more novel adjunctive therapeutic measures.</description><identifier>ISSN: 1738-5520</identifier><identifier>EISSN: 1738-5555</identifier><identifier>DOI: 10.4070/kcj.2019.0292</identifier><identifier>PMID: 31845552</identifier><language>eng</language><publisher>Korea (South): The Korean Society of Cardiology</publisher><subject>Review ; 내과학</subject><ispartof>Korean Circulation Journal, 2020, 50(3), , pp.203-219</ispartof><rights>Copyright © 2020. The Korean Society of Cardiology.</rights><rights>Copyright © 2020. The Korean Society of Cardiology 2020 The Korean Society of Cardiology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c421t-aa1c6f4c6ccaac8bc38de75b102ebe190da8810c20c5253be5d6c80ba437ad6b3</citedby><cites>FETCH-LOGICAL-c421t-aa1c6f4c6ccaac8bc38de75b102ebe190da8810c20c5253be5d6c80ba437ad6b3</cites><orcidid>0000-0003-4689-9982 ; 0000-0003-3912-1486 ; 0000-0002-8049-5618 ; 0000-0002-5643-5076 ; 0000-0003-4793-7741</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7043965/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7043965/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,724,777,781,882,27905,27906,53772,53774</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31845552$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART002558871$$DAccess content in National Research Foundation of Korea (NRF)$$Hfree_for_read</backlink></links><search><creatorcontrib>Bhaskaran, Ashwin</creatorcontrib><creatorcontrib>De Silva, Kasun</creatorcontrib><creatorcontrib>Rao, Karan</creatorcontrib><creatorcontrib>Campbell, Timothy</creatorcontrib><creatorcontrib>Trivic, Ivana</creatorcontrib><creatorcontrib>Bennett, Richard G</creatorcontrib><creatorcontrib>Kizana, Eddy</creatorcontrib><creatorcontrib>Kumar, Saurabh</creatorcontrib><title>Ventricular Tachycardia Ablation in Non-ischemic Cardiomyopathy</title><title>Korean circulation journal</title><addtitle>Korean Circ J</addtitle><description>Non-ischemic cardiomyopathies are a heterogeneous group of diseases of the myocardium that have a distinct proclivity to ventricular arrhythmias. Of these, ventricular tachycardias pose significant management challenges with the risk of sudden cardiac death and morbidity from multiple causes. Catheter ablation of ventricular tachycardias is becoming an increasingly utilised intervention that has been found to have significant benefits with improving symptoms, reducing anti-arrhythmic drug burden and debilitating device therapies, thereby improving quality of life. Nonetheless, the approach to the ablation of ventricular tachycardias in non-ischemic cardiomyopathies is governed heavily by the disease process, with several distinct differences from ischemic cardiomyopathy including a preponderance to epicardial and deep intramural substrate. This contemporary review aims to present the various disease processes within non-ischemic cardiomyopathies, catheter ablation techniques which have been developed to target ventricular tachycardia and more novel adjunctive therapeutic measures.</description><subject>Review</subject><subject>내과학</subject><issn>1738-5520</issn><issn>1738-5555</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNpVkctLw0AQxhdRfB-9So56SN1Xks1FKcUXiIJUr8tksrXbJtm6SYX-925sLTqXGZjffDPDR8gZowNJM3o1x9mAU5YPKM_5DjlkmVBxEmJ3W3N6QI7adkZpKiXP98mBYEoGhB-Sm3fTdN7isgIfjQGnKwRfWoiGRQWddU1km-jZNbFtcWpqi9Go77t65RbQTVcnZG8CVWtON_mYvN3djkcP8dPL_eNo-BSj5KyLARimE4kpIgCqAoUqTZYUjHJTGJbTEpRiFDnFhCeiMEmZoqIFSJFBmRbimFyudRs_0XO02oH9yR9Oz70evo4fdaoyldA8sNdrdrEsalNi_yFUeuFtDX71M_m_09hp0PnSGZUiT5MgcLER8O5zadpO1-F9U1XQGLdsNRc8yyVLchnQeI2id23rzWS7hlHdGxSOnOneIN0bFPjzv7dt6V9HxDeVU41-</recordid><startdate>20200301</startdate><enddate>20200301</enddate><creator>Bhaskaran, Ashwin</creator><creator>De Silva, Kasun</creator><creator>Rao, Karan</creator><creator>Campbell, Timothy</creator><creator>Trivic, Ivana</creator><creator>Bennett, Richard G</creator><creator>Kizana, Eddy</creator><creator>Kumar, Saurabh</creator><general>The Korean Society of Cardiology</general><general>대한심장학회</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>ACYCR</scope><orcidid>https://orcid.org/0000-0003-4689-9982</orcidid><orcidid>https://orcid.org/0000-0003-3912-1486</orcidid><orcidid>https://orcid.org/0000-0002-8049-5618</orcidid><orcidid>https://orcid.org/0000-0002-5643-5076</orcidid><orcidid>https://orcid.org/0000-0003-4793-7741</orcidid></search><sort><creationdate>20200301</creationdate><title>Ventricular Tachycardia Ablation in Non-ischemic Cardiomyopathy</title><author>Bhaskaran, Ashwin ; De Silva, Kasun ; Rao, Karan ; Campbell, Timothy ; Trivic, Ivana ; Bennett, Richard G ; Kizana, Eddy ; Kumar, Saurabh</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c421t-aa1c6f4c6ccaac8bc38de75b102ebe190da8810c20c5253be5d6c80ba437ad6b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Review</topic><topic>내과학</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bhaskaran, Ashwin</creatorcontrib><creatorcontrib>De Silva, Kasun</creatorcontrib><creatorcontrib>Rao, Karan</creatorcontrib><creatorcontrib>Campbell, Timothy</creatorcontrib><creatorcontrib>Trivic, Ivana</creatorcontrib><creatorcontrib>Bennett, Richard G</creatorcontrib><creatorcontrib>Kizana, Eddy</creatorcontrib><creatorcontrib>Kumar, Saurabh</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Korean Citation Index</collection><jtitle>Korean circulation journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bhaskaran, Ashwin</au><au>De Silva, Kasun</au><au>Rao, Karan</au><au>Campbell, Timothy</au><au>Trivic, Ivana</au><au>Bennett, Richard G</au><au>Kizana, Eddy</au><au>Kumar, Saurabh</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ventricular Tachycardia Ablation in Non-ischemic Cardiomyopathy</atitle><jtitle>Korean circulation journal</jtitle><addtitle>Korean Circ J</addtitle><date>2020-03-01</date><risdate>2020</risdate><volume>50</volume><issue>3</issue><spage>203</spage><epage>219</epage><pages>203-219</pages><issn>1738-5520</issn><eissn>1738-5555</eissn><abstract>Non-ischemic cardiomyopathies are a heterogeneous group of diseases of the myocardium that have a distinct proclivity to ventricular arrhythmias. Of these, ventricular tachycardias pose significant management challenges with the risk of sudden cardiac death and morbidity from multiple causes. Catheter ablation of ventricular tachycardias is becoming an increasingly utilised intervention that has been found to have significant benefits with improving symptoms, reducing anti-arrhythmic drug burden and debilitating device therapies, thereby improving quality of life. Nonetheless, the approach to the ablation of ventricular tachycardias in non-ischemic cardiomyopathies is governed heavily by the disease process, with several distinct differences from ischemic cardiomyopathy including a preponderance to epicardial and deep intramural substrate. This contemporary review aims to present the various disease processes within non-ischemic cardiomyopathies, catheter ablation techniques which have been developed to target ventricular tachycardia and more novel adjunctive therapeutic measures.</abstract><cop>Korea (South)</cop><pub>The Korean Society of Cardiology</pub><pmid>31845552</pmid><doi>10.4070/kcj.2019.0292</doi><tpages>17</tpages><orcidid>https://orcid.org/0000-0003-4689-9982</orcidid><orcidid>https://orcid.org/0000-0003-3912-1486</orcidid><orcidid>https://orcid.org/0000-0002-8049-5618</orcidid><orcidid>https://orcid.org/0000-0002-5643-5076</orcidid><orcidid>https://orcid.org/0000-0003-4793-7741</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1738-5520 |
ispartof | Korean Circulation Journal, 2020, 50(3), , pp.203-219 |
issn | 1738-5520 1738-5555 |
language | eng |
recordid | cdi_nrf_kci_oai_kci_go_kr_ARTI_6878509 |
source | Open Access: PubMed Central |
subjects | Review 내과학 |
title | Ventricular Tachycardia Ablation in Non-ischemic Cardiomyopathy |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T06%3A42%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_nrf_k&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ventricular%20Tachycardia%20Ablation%20in%20Non-ischemic%20Cardiomyopathy&rft.jtitle=Korean%20circulation%20journal&rft.au=Bhaskaran,%20Ashwin&rft.date=2020-03-01&rft.volume=50&rft.issue=3&rft.spage=203&rft.epage=219&rft.pages=203-219&rft.issn=1738-5520&rft.eissn=1738-5555&rft_id=info:doi/10.4070/kcj.2019.0292&rft_dat=%3Cproquest_nrf_k%3E2327941594%3C/proquest_nrf_k%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c421t-aa1c6f4c6ccaac8bc38de75b102ebe190da8810c20c5253be5d6c80ba437ad6b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2327941594&rft_id=info:pmid/31845552&rfr_iscdi=true |